L01XC: Monoklonale Antikörper

Alemtuzumab

View Details →

Atezolizumab

View Details →

Avelumab

View Details →

Belantamab mafodotin

View Details →

Bermekimab

View Details →

Bevacizumab

View Details →

Blinatumomab

View Details →

Brentuximab vedotin

View Details →

Catumaxomab

View Details →

Cemiplimab

View Details →

Cetuximab

View Details →

Daratumumab

View Details →

Dinutuximab beta

View Details →

Dostarlimab

View Details →

Durvalumab

View Details →

Edrecolomab

View Details →

Elotuzumab

View Details →

Enfortumab vedotin

View Details →

Gemtuzumab ozogamicin

View Details →

Inotuzumab ozogamicin

View Details →

Ipilimumab

View Details →

Isatuximab

View Details →

Mogamulizumab

View Details →

Moxetumomab pasudotox

View Details →

Necitumumab

View Details →

Nivolumab

View Details →

Obinutuzumab

View Details →

Ofatumumab

View Details →

Olaratumab

View Details →

Panitumumab

View Details →

Pembrolizumab

View Details →

Pertuzumab

View Details →

Polatuzumab vedotin

View Details →

Ramucirumab

View Details →

Rituximab

View Details →

Tafasitamab

View Details →

Trastuzumab

View Details →

Trastuzumab emtansin

View Details →